{"id":"NCT02157376","sponsor":"AstraZeneca","briefTitle":"Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill Patients","officialTitle":"Effect of Intravenous Esomeprazole Versus Cimetidine in Prevention of Stress Ulcer Prophylaxis in Chinese Seriously Ill Patients - a Randomized, Double-blind, Parallel-group Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-07","primaryCompletion":"2016-02","completion":"2016-02","firstPosted":"2014-06-06","resultsPosted":"2017-01-23","lastUpdate":"2017-03-10"},"enrollment":343,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Stress Ulcer Prophylaxis"],"interventions":[{"type":"DRUG","name":"Esomeprazole","otherNames":["Nexium"]},{"type":"DRUG","name":"Cimetidine","otherNames":["Tagamet"]}],"arms":[{"label":"Esomeprazole active treatment","type":"EXPERIMENTAL"},{"label":"Cimetidine active treatment","type":"ACTIVE_COMPARATOR"}],"summary":"The efficacy of esomeprazole will be compared versus cimetidine (a drug that previously demonstrated prevention of bleeding events) during treatment period in proportion of patients for the prevention of upper GI bleeding.","primaryOutcome":{"measure":"The Percent of Patients With Clinically Significant Upper-GI Bleeding During the Treatment Evaluation Phase","timeFrame":"1-14 days","effectByArm":[{"arm":"Esomeprazole","deltaMin":2.7,"sd":null},{"arm":"Cimetidine","deltaMin":4.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.393"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":15,"countries":["China"]},"refs":{"pmids":["29638148"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":153},"commonTop":["Lung infection","Pyrexia","Hypokalaemia","Anaemia","Constipation"]}}